Table 3.
1999–2012 Blood Pressure Trends and Projection to 2020 in NHANES Participants Reporting Prior MI, by Sex
| 1999–2000 | 2001–2002 | 2003–2004 | 2005–2006 | 2007–2008 | 2009–2010 | 2011–2012 | β (SE) | P (Trend) | R 2 | 2020 (Projected) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Men, N (total) | 126 | 142 | 158 | 142 | 177 | 182 | 120 | ||||
| Treated, N (% of total) | 86 (60.4) | 108 (73.8) | 124 (76.1) | 119 (84.5) | 150 (85.4) | 145 (74.0) | 103 (81.7) | 0.65 (0.81) | 0.45 | 0.12 | 100% |
| Controlled, N (% of treated) | 53 (67.8) | 55 (60.9) | 69 (58.7) | 85 (70.3) | 95 (67.7) | 99 (72.4) | 68 (68.2) | 0.46 (0.39) | 0.29 | 0.22 | 80% |
| Systolic BP, M (SE) | 127.9 (2.0) | 128.9 (3.1) | 129.3 (2.3) | 124.0 (2.5) | 127.4 (1.6) | 122.8 (1.2) | 127.6 (2.6) | −0.27 (0.23) | 0.29 | 0.22 | 122.8 |
| Diastolic BP, M (SE) | 68.8 (1.1) | 67.7 (1.7) | 67.9 (1.5) | 68.1 (1.4) | 67.8 (1.4) | 64.5 (1.2) | 68.1 (1.0) | −0.15 (0.13) | 0.29 | 0.22 | 65.3 |
| Untreated, N (% of total) | 40 (39.6) | 34 (26.2) | 34 (23.9) | 23 (15.5) | 27 (14.6) | 37 (26.0) | 17 (18.3) | −0.65 (0.81) | 0.45 | 0.12 | 0% |
| At goal, N (% of untreated) | 10 (32.1) | 15 (57.9) | 8 (18.0) | 6 (38.9) | 7 (33.2) | 12 (27.4) | 4 (34.7) | −0.35 (1.16) | 0.77 | 0.02 | 20% |
| Systolic BP, M (SE) | 125.9 (3.1) | 118.7 (1.1) | 131.2 (2.9) | 124.2 (3.3) | 125.5 (1.2) | 123.2 (3.2) | 124.0 (4.0) | −0.04 (0.39) | 0.91 | 0.002 | 124.0 |
| Diastolic BP, M (SE) | 76.0 (1.9) | 70.1 (1.9) | 72.5 (1.0) | 67.6 (2.4) | 75.1 (1.7) | 74.1 (2.8) | 73.0 (4.0) | 0.03 (0.31) | 0.94 | 0.002 | 73.0 |
| Women, N (total) | 61 | 69 | 98 | 66 | 90 | 76 | 73 | ||||
| Treated, N (% of total) | 47 (76.5) | 57 (85.3) | 80 (77.9) | 54 (78.4) | 71 (76.6) | 65 (79.8) | 68 (86.2) | −0.21 (0.46) | 0.66 | 0.04 | 87% |
| Controlled, N (% of treated) | 18 (48.4) | 31 (60.0) | 34 (39.7) | 37 (54.8) | 38 (56.1) | 43 (73.8) | 37 (58.3) | 1.73 (1.11) | 0.18 | 0.33 | 85% |
| Systolic BP, M (SE) | 137.2 (4.9) | 131.0 (4.4) | 136.4 (3.6) | 133.4 (2.8) | 132.9 (3.1) | 124.8 (3.7) | 131.5 (3.3) | −0.59 (0.33) | 0.13 | 0.39 | 123.6 |
| Diastolic BP, M (SE) | 64.5 (2.2) | 62.3 (2.2) | 64.7 (2.2) | 62.1 (2.0) | 65.5 (1.8) | 63.3 (1.8) | 64.3 (2.1) | 0.04 (0.13) | 0.78 | 0.02 | 64.4 |
| Untreated, N (% of total) | 14 (23.5) | 12 (14.7) | 18 (22.1) | 12 (21.6) | 19 (23.4) | 11 (20.2) | 5 (13.8) | 0.21 (0.46) | 0.66 | 0.04 | 13% |
| At goal, N (% of untreated) | 5 (62.9) | 2 (12.2) | 2 (5.8) | 6 (50.4) | 6 (22.9) | 6 (55.5) | 2 (33.5) | 3.97 (4.23) | 0.40 | 0.18 | 41% |
| Systolic BP, M (SE) | 121.1 (8.5) | 153.8 (12.0) | 130.4 (1.6) | 121.7 (1.6) | 136.0 (6.1) | 113.7 (5.1) | 117.0 (0.0) | −1.55 (1.25) | 0.27 | 0.24 | 104.4 |
| Diastolic BP, M (SE) | 59.4 (6.2) | 70.8 (3.4) | 68.8 (1.0) | 67.8 (0.7) | 76.6 (2.2) | 63.7 (5.3) | 63.0 (0.0) | 0.08 (0.59) | 0.90 | 0.003 | 68.3 |
Blood pressure listed in mm Hg. Untreated individuals at goal had a blood pressure <120/80 mm Hg. β coefficients represent the change in treatment or control prevalence or risk factor level per year. BP indicates blood pressure; MI, myocardial infarction; NHANES, National Health and Nutrition Examination Survey.